Shingo Horimoto
Direktor/Vorstandsmitglied bei Rena Therapeutics, Inc.
Ursprung des Netzwerks ersten Grades von Shingo Horimoto
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Rena Therapeutics, Inc.
 Rena Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Rena Therapeutics Inc. engages in the provision of third platform technology specifically for creation of new nucleic acid drugs. It offers joint collaborative search business, basic technology licensing and nucleic acid drug development business. The company was founded by Junichi Yano, Takashi Yamamoto and Takanori Yokota on January 15, 2015 and is headquartered in Tokyo, Japan.
3
| Subsidiary | Pharmaceuticals: Other | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Shingo Horimoto
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
TAK-Circulator Corp.
 TAK-Circulator Corp. Medical SpecialtiesHealth Technology TAK-Circulator Corp. develops and manufactures diagnostic substances. The Japanese company was founded in 2014 by Aikou Okamoto. | Medical Specialties | Director/Board Member |
Statistik
International
| Japan | 2 |
Sektoral
| Health Technology | 2 |
Operativ
| Director/Board Member | 3 |
| President | 2 |
| Chief Executive Officer | 1 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Shuichi Toriya | 2 |
| Jun Sasaki | 1 |
| Shoichi Iwamoto | 1 |
- Börse
- Insiders
- Shingo Horimoto
- Unternehmensverbindungen
